agent-797
mink therapeutics
['agent']
dr. david einstein will present clinical data from our ph1 study of agent-797 in solid tumor cancers. we have seen the cells can be administered tolerably at multiple doses, both alone &amp; in combination with anti-pd-1. check our presentation on nov 10 at sitc for more data.#sitc22 